| Angela Wang, | |
|
8401 Connecticut Ave Ste 201, Chevy Chase, MD 20815-5829 | |
| (301) 907-3960 | |
| Not Available |
| Full Name | Angela Wang |
|---|---|
| Gender | Female |
| Speciality | Pediatrics |
| Location | 8401 Connecticut Ave Ste 201, Chevy Chase, Maryland |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1568812089 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 208000000X | Pediatrics | D0098155 (Maryland) | Primary |
| 208000000X | Pediatrics | MT210839 (Pennsylvania) | Secondary |
| Mailing Address | Practice Location Address |
|---|---|
| Angela Wang, 8401 Connecticut Ave Ste 201, Chevy Chase, MD 20815-5829 Ph: (301) 907-3960 | Angela Wang, 8401 Connecticut Ave Ste 201, Chevy Chase, MD 20815-5829 Ph: (301) 907-3960 |
News Archive
Cancer Research UK expects around two million people to be diagnosed with cancer in the UK during the length of the next parliament according to new figures released today (Wednesday).
The study, published in the journal Proceedings of the National Academy of Sciences, showed that older, obese people who have an acute COVID-19 infection release more aerosols, increasing viral transmission potential.
Santarus, Inc., a specialty biopharmaceutical company, has expanded its development pipeline with the addition of two novel biologic drug candidates focused on specialty markets.
ThromboGenics NV, a biopharmaceutical company focused on developing innovative ophthalmic medicines, today announces that the US Food and Drug Administration (FDA) has notified the Company that its new biologic license application (BLA) for ocriplasmin intravitreal injection will be discussed at the Dermatologic and Ophthalmic Drugs Advisory Committee scheduled for July 26, 2012.
Cell Therapeutics, Inc. (CTI) today announced the presentation of findings from a preclinical study of PIXUVRI® (pixantrone) that suggest its mechanism of inducing tumor cell death is novel and distinct from that of anthracyclines such as doxorubicin.
› Verified 9 days ago
Mrs. Linda Goldstein, MD Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 4601 N Park Ave, Suite 8c, Chevy Chase, MD 20815 Phone: 301-656-2745 Fax: 301-718-7681 | |
Rebecca M Gross, MD Pediatrics Medicare: Accepting Medicare Assignments Practice Location: 8401 Connecticut Ave Ph Suite, Chevy Chase, MD 20815 Phone: 301-942-2122 Fax: 301-942-1149 | |
Ryan Mcdonald Walley, M.D. Pediatrics Medicare: Medicare Enrolled Practice Location: 8401 Connecticut Ave Ste 201, Chevy Chase, MD 20815 Phone: 301-907-3960 Fax: 301-652-4933 | |
Katharina Blunschi, MD Pediatrics Medicare: Medicare Enrolled Practice Location: 8401 Connecticut Ave, Chevy Chase, MD 20815 Phone: 301-907-3960 | |
John F. O'neill, MD Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 2 Wisconsin Cir, Suite 200, Chevy Chase, MD 20815 Phone: 301-215-7100 | |
Dr. Gary Don Crouch, MD Pediatrics Medicare: Medicare Enrolled Practice Location: 8017 Glengalen Ln, Chevy Chase, MD 20815 Phone: 301-951-8001 | |
Deborah Lindsey, MD Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 6008 Highland Dr, Chevy Chase, MD 20815 Phone: 301-651-2320 Fax: 301-652-7116 |